Results 41 to 50 of about 4,335,239 (285)

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir‑era

Journal of Public Health in Africa, 2023
Poor internet infrastructure limits the use of computer-based nursing process forms in rural areas. This study aimed to configure a computer‑based nursing process form to support nursing diagnosis and care evaluation in rural healthcare clinics in Africa.
Willy L.R.T. Pabo, Debimeh Njume, Roland N. Ndip, Desiré Takou, Maria-Mercedes Santoro, Collins Chenwi, Grace Beloumou, Ezechiel N.J. Semengue, Alex D. Nka, Aude C. Ka'e, Georges Teto, Beatrice Dambaya, Sandrine Djupsa, Raymond B. Nyasa, Davy H.G. Anguechia, Cedric Kamta, Lionel Bala, Virginie Lambo, Samuel M. Sosso, Vittorio Colizzi, Carlo F. Perno, Joseph Fokam, Alexis Ndjolo   +22 more
doaj   +1 more source

LRC: Dependency-Aware Cache Management for Data Analytics Clusters

, 2017
Memory caches are being aggressively used in today's data-parallel systems such as Spark, Tez, and Piccolo. However, prevalent systems employ rather simple cache management policies--notably the Least Recently Used (LRU) policy--that are oblivious to the
Letaief, Khaled Ben, Wang, Wei, Yu, Yinghao, Zhang, Jun   +3 more
core   +2 more sources

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin   +14 more
wiley   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Management of Biesboch reservoirs for quality control with special reference to eutrophication [PDF]

, 1992
The three Biesbosch Reservoirs are pumped storage reservoirs, fed with rather polluted and highly eutrophic water from the River Meuse. Air injection at the bottom of the reservoirs prevents thermal stratification, which would otherwise result in serious
Oskam, G., van Breemen, L.
core  

Long‐Term Outcomes of Pulmonary Vein Isolation in Patients With Brugada Syndrome and Paroxysmal Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Pharmacological treatment of atrial fibrillation (AF) in the setting of Brugada syndrome (BrS) is challenging. In addition, patients with BrS with an implantable cardioverter‐defibrillator (ICD) might experience inappropriate shocks for fast ...
Antonio Bisignani, Giulio Conte, Luigi Pannone, Juan Sieira, Alvise Del Monte, Felicia Lipartiti, Gezim Bala, Vincenzo Miraglia, Cinzia Monaco, Erwin Ströker, Ingrid Overeinder, Alexandre Almorad, Anaïs Gauthey, Livia Franchetti Pardo, Matthias Raes, Olivier Detriche, Pedro Brugada, Angelo Auricchio, Gian‐Battista Chierchia, Carlo de Asmundis   +19 more
doaj   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait, R. Al‐Saadi, A. Lopez‐Cortes, K. Dzhuma, M. Oostveen, J. Brok, S. Irtan, M. Weeks, J. Bate, S. Baker, R. Williams, M. Powis, D. Saunders, O. Olsen, T. Watson, S. Shelmerdine, S. Vaidya, L. Howell, C. Duncan, G. M. Vujanic, C. Stiller, G. P. Balchin, T. Chowdhury, K. Pritchard‐Jones   +23 more
wiley   +1 more source

Cryoballoon ablation for atrial fibrillation: Effects on neuromodulation

Frontiers in Cardiovascular Medicine, 2022
Pulmonary vein isolation (PVI) represents the mainstay of atrial fibrillation (AF) ablation, and PVI with cryoballoon catheter (CB) ablation (CB-A) has proven to be as effective and safe as radiofrequency ablation (RF-A).
Alvise Del Monte, Luigi Pannone, Antonio Bisignani, Thiago G. Osório, Saverio Iacopino, Saverio Iacopino, Gian-Battista Chierchia, Carlo de Asmundis   +7 more
doaj   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source